Integrated medicament delivery device for use with continuous analyte sensor

US10966609B2 · kind B2 · utility

Assignee

• Dexcom, Inc. · US

Inventors

• Mark C. Brister · Encinitas, US
• Nelson Quintana · San Diego, US
• Antonio C. Llevares · Chula Vista, US
• John Michael Dobbles · San Clemente, US
• Richard C. Yang · Carlsbad, US
• Michael Robert Mensinger · San Diego, US

Key dates

• Filing date: Mar 19, 2019
• Grant date: Apr 6, 2021
• Expiry date: Jul 27, 2039

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61M2230/201
• WIPO field: Medical technology
• WIPO sector: Instruments

Abstract

An integrated system for the monitoring and treating diabetes is provided, including an integrated receiver/hand-held medicament injection pen, including electronics, for use with a continuous glucose sensor. In some embodiments, the receiver is configured to receive continuous glucose sensor data, to calculate a medicament therapy (e.g., via the integrated system electronics) and to automatically set a bolus dose of the integrated hand-held medicament injection pen, whereby the user can manually inject the bolus dose of medicament into the host. In some embodiments, the integrated receiver and hand-held medicament injection pen are integrally formed, while in other embodiments they are detachably connected and communicated via mutually engaging electrical contacts and/or via wireless communication.